No Prescription |
 |
 | ||
|
Daktagold Nizoral |
|
| ||
No Prescription » Prescription Drugs 5 » Daktagold Nizoral Ketoconazole is used to treat skin infections such as athlete's foot jock itch ringworm and certain kinds of dandruff. This medication is also used to treat a skin condition known as pityriasis (tinea versicolor) a fungal infection that causes a lightening or darkening of the skin of the neck chest arms or legs. Ketoconazole is an azole antifungal that works by preventing the growth of fungus.How to use Ketoconazole TopUse this medication on the skin only. Clean and thoroughly dry the area to be treated. Apply this medication to the affected skin usually once or twice a day or as directed by your doctor. Dosage and length of treatment depends on the type of infection being treated. Do not apply this more often than prescribed. Your condition will not clear faster but side effects may be increased.Apply enough medication to cover the affected skin and some of the surrounding skin. After applying this medication wash your hands. Do not wrap cover or bandage the area unless directed to do so by your doctor.Do not apply this medication in the eyes nose mouth or vagina. If this medication gets in the eyes (e.g. when used to treat dandruff) rinse thoroughly with water.Use this medication regularly in order to get the most benefit from it. Remember to use it at the same time(s) each day.Continue to use this medication until the full prescribed amount is finished even if symptoms disappear after starting ketoconazole. Stopping the medication too early may allow the fungus to continue to grow which may result in a relapse of the infection. Buy Daktagold Nizoral and other Prescription Drugs 5 products online at Medstore. Buy Online at Medstore - Click Here!
About Daktagold Nizoral: Product Type: Prescription Drugs 5 Daktagold ( Nizoral Generic Ketoconazole ) Daktagold (Nizoral Generic Ketoconazole) Nizoral Generic Ketoconazole Cream 30gm 3 x 30gm Nizoral Generic Ketoconazole Daktagold
View more Prescription Drugs 5 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
